Get the Stockscreener App
1.84
3.66%
-0.07
Alector Inc stock is traded at $1.84, with a volume of 5.15M.
It is down -3.66% in the last 24 hours and down -4.42% over the past month.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
See More
Previous Close:
$1.91
Open:
$2.18
24h Volume:
5.15M
Relative Volume:
0.40
Market Cap:
$205.45M
Revenue:
$21.05M
Net Income/Loss:
$-142.93M
P/E Ratio:
-1.3242
EPS:
-1.3895
Net Cash Flow:
$-184.07M
1W Performance:
-11.54%
1M Performance:
-4.42%
6M Performance:
-27.84%
1Y Performance:
-42.86%
1-Day Range:
$1.7901
$2.18
1-Week Range:
$1.775
$2.18
52-Week Range:
$1.09
$3.3999
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.84 | 205.45M | 21.05M | -142.93M | -184.07M | -1.3895 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-10-26 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
ALEC Stock Draws Fresh 13G Stake As Trading Heats Up - Timothy Sykes
ALEC Stock Pops As New 13G Stake Draws Trader Focus - Timothy Sykes
A Parkinson’s drug deal could mean up to $1.17 billion for Alector if future goals are met. - Stock Titan
Biotechnology Value Fund group discloses 8.4% stake in Alector (ALEC) - Stock Titan
Alector at Cantor healthcare conference: brain-shuttle pipeline in focus By Investing.com - Investing.com Canada
Alector at Cantor healthcare conference: brain-shuttle pipeline in focus - investing.com
Alector at Cantor healthcare conference: brain-shuttle pipeline in focus By Investing.com - Investing.com UK
Alector CFO Berkley Neil Lindsay Sells 29,251 Shares at $2.66 Each (NASDAQ: ALEC) - Kalkine Media
Don't Ignore The Insider Selling In Alector - simplywall.st
Don't Ignore The Insider Selling In Alector - simplywall.st
Alector CEO Arnon Rosenthal sells $193,473 in stock By Investing.com - Investing.com South Africa
Alector CFO Neil Berkley sells $77,948 of ALEC shares By Investing.com - Investing.com Australia
Alector | 4: Statement of changes in beneficial ownership of securities - Moomoo
Alector’s Grace Wong-Sarad sells $24,665 in shares By Investing.com - Investing.com India
Alector’s Grace Wong-Sarad sells $24,665 in shares By Investing.com - Investing.com Canada
Alector’s Grace Wong-Sarad sells $24,665 in shares By Investing.com - Investing.com Nigeria
Alector | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Alector CEO Arnon Rosenthal sells $193,473 in stock By Investing.com - Investing.com Australia
Alector CFO Neil Berkley sells $77,948 of ALEC shares By Investing.com - Investing.com Nigeria
Alector’s Grace Wong-Sarad sells $24,665 in shares By Investing.com - Investing.com Australia
Alector’s Grace Wong-Sarad sells $24,665 in shares - investing.com
Alector CFO Neil Berkley sells $77,948 of ALEC shares By Investing.com - Investing.com South Africa
Alector CEO Arnon Rosenthal sells $193,473 in stock By Investing.com - Investing.com Canada
Alector CFO Neil Berkley sells $77,948 of ALEC shares By Investing.com - Investing.com South Africa
Alector’s Grace Wong-Sarad sells $24,665 in shares By Investing.com - Investing.com South Africa
Alector CEO Arnon Rosenthal sells $193,473 in stock By Investing.com - Investing.com India
Alector CEO Arnon Rosenthal sells $193,473 in stock By Investing.com - Investing.com UK
Alector CEO Arnon Rosenthal sells $193,473 in stock - Investing.com
Preset trades at Alector (NASDAQ: ALEC) move 9,446 insider shares - Stock Titan
Alector (ALEC) CFO sells stock to cover RSU tax bill - Stock Titan
Alector (NASDAQ: ALEC) officer lines up another stock sale - Stock Titan
Alector CFO Neil Berkley sells $77,948 of ALEC shares By Investing.com - Investing.com Canada
Alector CFO Neil Berkley sells $77,948 of ALEC shares - Investing.com
Alector (ALEC) CEO sells 72,606 shares to cover RSU taxes - Stock Titan
Alector CEO Arnon Rosenthal sells $193,473 in stock - Investing.com
Alector to Participate in Upcoming Healthcare Conferences - Yahoo Finance
Officer at Alector (NASDAQ: ALEC) lines up new stock sale after 3,475-share trade - Stock Titan
Alector Inc. (ALEC) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Tax-driven sale of 79K Alector (NASDAQ: ALEC) shares planned - Stock Titan
Alector (NASDAQ: ALEC) insider to sell RSU shares to cover taxes - Stock Titan
RSU taxes drive Alector (NASDAQ: ALEC) insider's 11K-share sale plan - Stock Titan
Alector Inc. (ALEC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Alector (ALEC) Update: Finishes 2.54% Down at $2.30 on the Day; Chart View: the Supplied Trading Band Runs From $2.18 to $2.42 in the Latest SessionSafe Entry Stocks - vinanet.vn
Alector (ALEC) Update: Finishes 2.54% Down at $2.30 on the Day; Chart View: the Supplied Trading Band Runs From $2.18 to $2.42 in the Latest SessionIV Percentile - dars.gov.et
Alector (ALEC) CEO shifts 2.1M shares into family trusts - Stock Titan
Alector (ALEC) Results at a Glance: EPS Lands Above Forecast in Latest Trading; Latest Reaction: Shares Finish 9.95% Higher on the DayFree Cash Flow Trends - vinanet.vn
Alector (ALEC) Results at a Glance: EPS Lands Above Forecast in Latest Trading; Latest Reaction: Shares Finish 9.95% Higher on the DayEarnings Cycle Report - dars.gov.et
Merck & Co. Inc. Makes New $7.13 Billion Investment in Alector, Inc. $ALEC - MarketBeat
Alector, Inc. (NASDAQ:ALEC) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GRACE WONG-SARAD | Officer |
Sep 04 '26 |
Proposed Sale |
2.51 |
3,625 |
9,094 |
0 |
| Wong-Sarad Grace | Principal Accounting Officer |
Sep 04 '26 |
Sale |
2.51 |
3,625 |
9,094 |
106,015 |
| Berkley Neil Lindsay | CFO & Chief Business Officer |
Sep 03 '26 |
Sale |
2.66 |
29,251 |
77,948 |
350,649 |
| Rosenthal Arnon | Chief Executive Officer |
Sep 03 '26 |
Sale |
2.66 |
72,606 |
193,473 |
2,294,600 |
| GRACE WONG-SARAD | Officer |
Sep 02 '26 |
Proposed Sale |
2.75 |
656 |
1,804 |
0 |
| Grace Wong-Sarad | Officer |
Sep 02 '26 |
Proposed Sale |
2.40 |
5,662 |
13,589 |
0 |
| Wong-Sarad Grace | Principal Accounting Officer |
Sep 02 '26 |
Sale |
2.75 |
656 |
1,804 |
114,805 |
| Arnon Rosenthal | Officer |
Sep 02 '26 |
Proposed Sale |
2.40 |
79,702 |
191,285 |
0 |
| Neil L. Berkley | Officer |
Sep 02 '26 |
Proposed Sale |
2.40 |
32,103 |
77,047 |
0 |
| Wong-Sarad Grace | Principal Accounting Officer |
Jun 03 '26 |
Sale |
1.88 |
3,475 |
6,543 |
95,461 |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):